KR880004806A - 분무 건조 아세트아미노펜 - Google Patents

분무 건조 아세트아미노펜 Download PDF

Info

Publication number
KR880004806A
KR880004806A KR870011625A KR870011625A KR880004806A KR 880004806 A KR880004806 A KR 880004806A KR 870011625 A KR870011625 A KR 870011625A KR 870011625 A KR870011625 A KR 870011625A KR 880004806 A KR880004806 A KR 880004806A
Authority
KR
South Korea
Prior art keywords
acetaminophen
weight
powder
plasticizer
water
Prior art date
Application number
KR870011625A
Other languages
English (en)
Other versions
KR950013753B1 (ko
Inventor
죠지 블랭크 로버트
샨티랄 모디 디라
로버트 아지슴 개리
존 케니 라차드
Original Assignee
스탠리 에프·바샤이
아메리칸 홈 프로덕츠 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스탠리 에프·바샤이, 아메리칸 홈 프로덕츠 코포레이션 filed Critical 스탠리 에프·바샤이
Publication of KR880004806A publication Critical patent/KR880004806A/ko
Application granted granted Critical
Publication of KR950013753B1 publication Critical patent/KR950013753B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

분무 건조 아세트아미노펜
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 필수적으로, 분말의 중량을 기준하여, 아세트 아미노펜 약 63 내지 77중량%, 에틸 셀룰로즈 약 15 내지 30중량% 및 가소제 약 2 내지 7중량%로 이루어지며, 용해되거나 현탁된 가소제를 함유하는 물 중의 아세트 아미노펜 및 에틸 셀룰로즈의 분산액으로부터 분무 건조된 분무 건조 아세트아미노펜의 치료학적 분말.
  2. 제1항에 있어서, 가소제가 디부틸 세바케이트, 글리세린, 프로필렌 글리콜, 트리아세틴 또는 폴리에틸렌 글리콜인 분말.
  3. 용해되거나 현탁된 가소제를 함유하는 물중의 아세트아미노펜 및 에틸 셀룰로즈의 분산액을 분무 건조 시킴을 특징으로 하여, 필수적으로, 분말의 중량을 기준하여, 아세트아미노펜 약 63 내지 77중량%, 에틸 셀룰로즈 약 15 내지 30중량% 및 가소제 약 2 내지 7중량%로 이루어진 분무 건조 아세트아미노펜의 치료학적 분말을 제조하는 방법.
  4. 제3항에 있어서, 가소제가 디부틸 세바케이트, 글리세린, 프로필렌 글리콜, 트리아세틴 또는 폴리에틸렌 글리콜인 방법.
  5. 제1항 또는 2항에 청구된 치료학적 분말을 함유함을 특징으로 하는, 물에 의해 10초 이내에 붕해 될 수 있는 경구 투여용 약제학적 고체 용량 형태.
  6. 고체 용량 형태가 물에 의해 10초 이내에 붕해될 수 있도록, 단위 용량의 약제학적 물질을 담지(carring)하는, 약제학적 물질에 대해 불활성인 약제학적으로 허용되는 수용성 또는 수분산성 담체물질의 네트워크(이 네트워크는 약제학적 물질 및 용매 중의 담체물질의 용액을 함유하는 조성물로 부터 용매를 승화시킴으로써 고체 상태로 수득된다)를 함유하는 고체용량형태에 있어서, 약제학적 물질이 제1항 또는 2항에 청구된 치료학적 분말임을 특징으로 하는 경구투여용 약제학적 고체 용량 형태.
  7. 제1항 또는 2항에 청구된 분말을 함유하는 씹을 수 있는 정제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870011625A 1986-10-21 1987-10-20 분무 건조된 아세트아미노펜, 이의 제조방법 및 이를 함유하는 약제학적 제형 KR950013753B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US921,658 1978-07-03
US921658 1986-10-21
US06/921,658 US4760094A (en) 1986-10-21 1986-10-21 Spray dried acetaminophen

Publications (2)

Publication Number Publication Date
KR880004806A true KR880004806A (ko) 1988-06-27
KR950013753B1 KR950013753B1 (ko) 1995-11-15

Family

ID=25445764

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870011625A KR950013753B1 (ko) 1986-10-21 1987-10-20 분무 건조된 아세트아미노펜, 이의 제조방법 및 이를 함유하는 약제학적 제형

Country Status (11)

Country Link
US (1) US4760094A (ko)
EP (1) EP0267702B1 (ko)
JP (1) JP2550362B2 (ko)
KR (1) KR950013753B1 (ko)
AT (1) ATE83923T1 (ko)
AU (1) AU588136B2 (ko)
CA (1) CA1291044C (ko)
DE (1) DE3783332T2 (ko)
ES (1) ES2052578T3 (ko)
GR (1) GR3006761T3 (ko)
IE (1) IE61951B1 (ko)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5198228A (en) * 1989-09-14 1993-03-30 Hoechst-Roussel Pharmaceuticals Inc. Direct dry compressible acetaminophen tablet
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition
US5358717A (en) * 1989-12-22 1994-10-25 Syntex (U.S.A.) Inc. Directly-compressible naproxen or naproxen sodium compositions
EP0580860B2 (en) * 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Method of manufacturing solid dispersion
EP0620728B1 (en) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation of tablets of increased strength
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU751497B2 (en) * 1996-04-23 2002-08-15 Mayne Pharma International Pty Ltd Taste masked pharmaceutical compositions
AUPN940796A0 (en) * 1996-04-23 1996-05-16 F.H. Faulding & Co. Limited Taste masked pharmaceutical compositions
AUPO637197A0 (en) * 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US6437000B1 (en) 1999-09-02 2002-08-20 Norstrum Pharmaceuticals, Inc. Controlled release oral dosage for suitable for oral administration
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
EP1295595A4 (en) * 2000-06-30 2008-04-02 Astellas Pharma Inc TABLET RAPIDLY DISINTEGRATING IN THE MOUTH AND CORRESPONDING PRODUCTION PROCESS
US6656492B2 (en) 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
EP2283829A1 (en) 2000-10-30 2011-02-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
US9925138B2 (en) 2015-01-20 2018-03-27 Handa Pharmaceuticals, Llc Stable solid fingolimod dosage forms
FI3562486T3 (fi) 2016-12-31 2024-06-04 Bioxcel Therapeutics Inc Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa
KR20210028192A (ko) 2018-06-27 2021-03-11 바이오엑셀 테라퓨틱스 인코포레이티드 덱스메데토미딘을 함유하는 필름 제형 및 이를 생산하는 방법
JP2022540706A (ja) 2019-07-19 2022-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420572B2 (ko) * 1973-04-27 1979-07-24
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
ATE17650T1 (de) * 1980-05-20 1986-02-15 Mallinckrodt Inc Trockenpulverisierte n-acetyl-p-aminophenolzusammensetzungenund verfahren zu deren herstellung.
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
DE3306012A1 (de) * 1983-02-22 1984-08-23 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung eines freifliessenden paracetamol-granulats
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
AU3880185A (en) * 1984-02-08 1985-08-27 R.P. Scherer Corporation Acetaminophen gelatin capsule
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
US4710519A (en) * 1985-09-30 1987-12-01 Basf Corporation Process for preparing spray dried acetaminophen powder and the powder prepared thereby

Also Published As

Publication number Publication date
EP0267702B1 (en) 1992-12-30
CA1291044C (en) 1991-10-22
IE872750L (en) 1988-04-21
EP0267702A3 (en) 1989-06-14
ES2052578T3 (es) 1994-07-16
DE3783332T2 (de) 1993-05-27
DE3783332D1 (de) 1993-02-11
EP0267702A2 (en) 1988-05-18
US4760094A (en) 1988-07-26
AU7950787A (en) 1988-04-28
ATE83923T1 (de) 1993-01-15
AU588136B2 (en) 1989-09-07
GR3006761T3 (ko) 1993-06-30
KR950013753B1 (ko) 1995-11-15
IE61951B1 (en) 1994-11-30
JP2550362B2 (ja) 1996-11-06
JPS63112514A (ja) 1988-05-17

Similar Documents

Publication Publication Date Title
KR880004806A (ko) 분무 건조 아세트아미노펜
KR880004804A (ko) 분무건조 아세트 아미노펜
KR880004803A (ko) 분무 건조된 아세트아미노펜
KR880004805A (ko) 분무건조된 아세트아미노펜
HUP0004050A2 (hu) Javított oldódású itrakonazol, eljárás ennek előállítására és ezt tartalmazó orális gyógyszerkészítmény
FR2334359A1 (fr) Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances
FI863889A0 (fi) Farmaceutisk produkt som laongsamt friger aktivt aemne.
DK531088D0 (da) Farmaceutiske praeparater af 1,8-diethyl-1,3,4,9-tetrahydropyrano 3,4-b-indol-1-eddikesyre eller salte deraf
NL7413848A (nl) Werkwijze voor de bereiding van farmacologisch werkzame 1,2-benzisoxazoolderivaten en gevormd farmaceutisch preparaat, dat een dezer stoffen
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
RU96100835A (ru) Способ получения флавано-лигнановых композиций с улучшенными высвобождением и всасываемостью, композиции, получаемые этим способом, содержащее их лекарственное средство и способ его получения
BE1002788A3 (fr) Composition pharmaceutique contenant un extrait vegetal et procede pour sa preparation.
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
FR2287916A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et medicament les contenant
BE764659A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
BE764660A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
KR960028916A (ko) 우수한 유리(遊離) 및 흡수능을 가진 플라바노리그난 제제
DE3764111D1 (de) Arzneimittelkombination.
BE845197R (fr) Nouveaux derives de l'indole, leur preparation et medicaments les contenant
FR2320090A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
BE826711A (fr) Derives d'indolylacetylamino-acide, leur procede de preparation et les compositions pharmaceutiques contenant ces composes
FR2347338A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et compositions pharmaceutiques les contenant
FR2292472A1 (fr) Nouveaux derives d'isoindole utiles en tant que medicaments, et leur procede de preparation
JPS55129220A (en) Composition for solid preparation containing hardly soluble medicinal component having rapid action and high bioavailability
BE773205A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19981029

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee